Decoy Therapeutics, Inc. (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, announces that the development of a ...

If your “microservices” still deploy like a monolith, maybe it’s time to break free with a truly composable AWS architecture.

MIT Technology Review today released its highly anticipated annual Innovation issue, featuring the 10 Breakthrough Technologies of 2026. Now in its 25th year, this inspiring and thought-provoking list ...

Former Akamai engineers are behind startup IO River, which is developing an edge platform that creates a virtualization layer across multiple CDN providers.